Studies have shown that the risk of biochemical recurrence, which is defined as increasing serum PSA levels, is around 25% in men who undergo radical prostatectomy, whereas the risk of prostate cancer specific mortality in the same group is 7–12%3, 4, 5. This evidence concerns the gene KLK3 and prostate cancer.